Hsbc Holdings PLC Catalyst Pharmaceuticals, Inc. Transaction History
Hsbc Holdings PLC
- $168 Billion
- Q4 2024
A detailed history of Hsbc Holdings PLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 36,337 shares of CPRX stock, worth $792,509. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,337
Previous 22,068
64.66%
Holding current value
$792,509
Previous $438,000
73.06%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CPRX
# of Institutions
348Shares Held
98.5MCall Options Held
13.4KPut Options Held
11.7K-
Black Rock Inc. New York, NY18.7MShares$408 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$184 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$126 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.13MShares$68.3 Million1.62% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.01MShares$65.7 Million0.02% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.24B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...